Analysts expect Rapport Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.00 M | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.68 M | 0.00 | 0.00 | 78,044.88 | 0.00 | 0.00 | -1.78 M | -2.38 M | 2.83 M | -829,196.29 | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.34 M | 0.00 | 0.00 | 72,942.42 | 0.00 | 0.00 | -1.99 M | -2.72 M | 2.38 M | -912,307.83 | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.01 M | 0.00 | 0.00 | 75,493.65 | 0.00 | 0.00 | -1.88 M | -2.55 M | 2.61 M | -870,752.06 |
Analysts expect Rapport Therapeutics, Inc. to report earnings per share of -1.13 for Q3 26, against a range of -1.24 to -1.02. The most recent reported quarter, Q2 26, came in at -1.19, a 17.8% miss against the -1.01 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.50 | -0.57 | -0.68 | -0.75 | -0.71 | -0.72 | -0.42 | -1.19 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.56 | -0.66 | -0.76 | -0.83 | -0.78 | -0.67 | -0.62 | -0.95 | -1.02 | -1.06 | -1.06 | -1.18 | -1.40 | -1.28 | -1.18 | -1.29 | ||||||||||
| Low Estimate | -0.62 | -0.70 | -0.86 | -0.89 | -0.84 | -0.77 | -0.68 | -1.07 | -1.24 | -1.22 | -1.26 | -1.26 | -1.52 | -1.50 | -1.36 | -1.43 | ||||||||||
| Consensus Estimate | -0.59 | -0.68 | -0.81 | -0.86 | -0.81 | -0.72 | -0.65 | -1.01 | -1.13 | -1.14 | -1.16 | -1.22 | -1.46 | -1.39 | -1.27 | -1.36 |
Pull Wall Street consensus for Rapport Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RAPP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RAPP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RAPP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();